2025
SJR Q2
JCR Q3 · 1,3
63 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Cardiovascular Surgery
- Yayıncı
- Edizioni Minerva Medica
- Ülke
- Italy · Western Europe
- Tür
- journal
- ISSN
-
002195091827191X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,483
- Quartile Q2
- H-Index 61
- Atıf/yayın 1,24
- Doküman (3y) 259
- Atıf (3y) 339
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,3
- 5Y JIF 1,3
- JCI 0,43
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q3
- Medicine (miscellaneous) Q3
- Surgery Q2
Alanlar
- Medicine
WoS kategorileri
- Cardiac & Cardiovascular System | Surgery | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,483 | 1,3 | 1,3 | 0,43 | Q3 | 61 |
| 2024 | Q2 | Q3 | 0,66 | 1,5 | 1,4 | 0,45 | Q3 | 59 |
| 2023 | Q2 | Q3 | 0,511 | 1,4 | 1,5 | 0,4 | Q3 | 59 |
| 2022 | Q2 | Q3 | 0,584 | 1,4 | 1,5 | 0,36 | Q3 | 59 |
| 2021 | Q2 | Q4 | 0,575 | 1,6 | 1,5 | 0,39 | Q3 | 59 |
| 2020 | Q2 | Q3 | 0,794 | 1,9 | 1,4 | 0,4 | Q3 | 59 |
| 2019 | Q2 | Q3 | 0,641 | 1,4 | 1,2 | 0,37 | Q3 | 59 |
| 2018 | — | Q4 | — | 1,1 | 1,2 | 0,34 | Q3 | — |
| 2017 | Q2 | Q3 | 0,651 | 1,2 | 1,2 | 0,38 | Q3 | 59 |
| 2016 | Q2 | Q2 | 0,706 | 2,2 | 1,6 | — | — | 59 |
| 2015 | Q2 | Q2 | 0,724 | 1,6 | 1,3 | — | — | 59 |
| 2014 | Q2 | Q3 | 0,741 | 1,5 | 1,4 | — | — | 59 |
| 2013 | Q1 | Q3 | 0,827 | 1,4 | 1,4 | — | — | 59 |
| 2012 | Q1 | Q2 | 0,886 | 1,5 | 1,3 | — | — | 59 |
| 2011 | Q2 | Q2 | 0,677 | 1,6 | 1,3 | — | — | 59 |
| 2010 | Q2 | Q2 | 0,664 | 1,4 | 1,4 | — | — | 59 |
| 2009 | — | Q3 | — | 1,2 | 1,4 | — | — | — |
| 2008 | — | Q2 | — | 1,5 | 1,3 | — | — | — |
| 2007 | — | Q2 | — | 1,6 | 1 | — | — | — |
| 2006 | — | Q3 | — | 1 | — | — | — | — |
| 2005 | — | Q3 | — | 0,8 | — | — | — | — |
| 2004 | — | Q3 | — | 0,8 | — | — | — | — |
| 2003 | — | Q2 | — | 1 | — | — | — | — |
| 2002 | — | Q3 | — | 0,5 | — | — | — | — |
| 2001 | — | Q3 | — | 0,6 | — | — | — | — |
| 2000 | — | Q3 | — | 0,6 | — | — | — | — |
| 1999 | — | Q3 | — | 0,5 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 184/237 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 76/100 |
| 2025 | SURGERY | SCIE | Q3 | Q3 | 210/321 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 149/231 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 73/98 |
| 2024 | SURGERY | SCIE | Q3 | Q3 | 175/314 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 152/222 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 72/96 |
| 2023 | SURGERY | SCIE | Q3 | Q3 | 166/292 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 130/143 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 62/68 |
| 2022 | SURGERY | SCIE | Q3 | Q3 | 159/213 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 130/143 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 60/67 |
| 2021 | SURGERY | SCIE | Q4 | Q3 | 163/213 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 115/142 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 56/65 |
| 2020 | SURGERY | SCIE | Q3 | Q3 | 140/211 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 112/138 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 56/65 |
| 2019 | SURGERY | SCIE | Q3 | Q3 | 141/210 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 124/136 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 61/65 |
| 2018 | SURGERY | SCIE | Q4 | Q3 | 161/203 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 110/128 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/65 |
| 2017 | SURGERY | SCIE | Q3 | Q3 | 145/200 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 68/126 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 41/63 |
| 2016 | SURGERY | SCIE | Q2 | — | 78/197 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 79/124 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 46/63 |
| 2015 | SURGERY | SCIE | Q2 | — | 92/200 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 81/123 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 50/60 |
| 2014 | SURGERY | SCIE | Q3 | — | 101/198 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 83/125 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 51/65 |
| 2013 | SURGERY | SCIE | Q3 | — | 104/204 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 72/124 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 45/68 |
| 2012 | SURGERY | SCIE | Q2 | — | 90/199 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 70/117 |
| 2011 | SURGERY | SCIE | Q2 | — | 81/199 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 77/114 |
| 2010 | SURGERY | SCIE | Q2 | — | 85/188 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 67/95 |
| 2009 | SURGERY | SCIE | Q3 | — | 91/167 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 50/79 |
| 2008 | SURGERY | SCIE | Q2 | — | 64/148 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 44/75 |
| 2007 | SURGERY | SCIE | Q2 | — | 50/139 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 58/74 |
| 2006 | SURGERY | SCIE | Q3 | — | 82/137 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 60/72 |
| 2005 | SURGERY | SCIE | Q3 | — | 87/139 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 56/71 |
| 2004 | SURGERY | SCIE | Q3 | — | 90/139 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 46/70 |
| 2003 | SURGERY | SCIE | Q2 | — | 65/141 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 60/66 |
| 2002 | SURGERY | SCIE | Q3 | — | 104/141 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 58/65 |
| 2001 | SURGERY | SCIE | Q3 | — | 101/139 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 51/63 |
| 2000 | SURGERY | SCIE | Q3 | — | 90/136 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 47/67 |
| 1999 | SURGERY | SCIE | Q3 | — | 95/131 |
| 1998 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 33/62 |
| 1998 | SURGERY | SCIE | Q3 | — | 65/128 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 36/62 |
| 1997 | SURGERY | SCIE | Q3 | — | 63/114 |